Haoxi Health Technology Limited (HAO) Stock Score, Valuation & Financial Research
Haoxi Health Technology Limited is in the Communication Services sector and Advertising Agencies industry. It is reviewed using Wall Street Score's company-strength, valuation, growth and financial-health framework. The current Wall Street Score is 37/100.
Quick answer for HAO
Haoxi Health Technology Limited currently has a Wall Street Score of 37/100. The stored market price is $2.87. Its financial score is 25/100. Its valuation score is 0/100. These figures are a research snapshot, not a buy or sell recommendation.
What Haoxi Health Technology Limited does
Haoxi Health Technology Limited, operating with its subsidiaries in China, specializes in providing digital marketing services. The company's offerings encompass online short video marketing, which it delivers to advertisers through its network of media partners, alongside custom-designed marketing strategies. These tailored solutions involve the careful planning, creation, distribution, and optimization of online advertisements across various digital platforms, all aimed at helping advertisers attract new customers, drive conversions, and cultivate consumer loyalty. Advertisements are strategically placed on leading online short video and social media platforms, including popular services like Toutiao, Douyin, WeChat, and Sina Weibo. Haoxi primarily serves an advertiser base within the healthcare industry. The company was founded in 2018 and is headquartered in Beijing, China.
HAO financial snapshot
- Wall Street Score:
- 37/100
- Current price:
- $2.87
- Market capitalization:
- $1.0M
- Revenue:
- $91.6M
- Net income:
- $-2.5M
- Free cash flow:
- $-3.4M
- Cash:
- $6.8M
- Total debt:
- $1.6M
- EPS:
- -1.62
- Financial score:
- 25/100
- Valuation score:
- 0/100
- Revenue score:
- 46/100
What stands out
- Reported year-over-year revenue growth is +1.8%.
- Free cash flow is $-3.4M, showing cash burn in the current stored period.
- The balance sheet shows $6.8M of cash versus $1.6M of total debt, leaving more cash than debt.
- The current research record carries a share basis reconciled warning, which should be reviewed alongside the score.
Questions worth answering for HAO
These questions are derived from the company's current stored financial and score data so the page adds company-specific research context instead of treating the headline score as a stand-alone conclusion.
- Can HAO maintain its current revenue growth rate and improve the amount of that revenue that turns into earnings and cash?
- How long can HAO fund negative free cash flow using its current cash position before it may need more debt or new shares?
- How is HAO likely to use its cash advantage: reinvestment, acquisitions, debt reduction, dividends or buybacks?
- What specifically needs to improve for HAO to reach sustainable profitability?
- What future growth or profitability would be needed to justify HAO's current valuation?
What the numbers mean
Its current valuation score is 0/100, which Wall Street Score classifies as weak within the model's valuation framework.
The financial score is 25/100. This is a starting point for reviewing liquidity, leverage and cash-flow strength rather than a stand-alone recommendation.
A strong company and an attractive stock price are not always the same thing. Revenue, earnings, free cash flow, debt, management quality, competitive advantage and valuation should be considered together. Wall Street Score organizes these inputs into a consistent research framework so investors can identify what deserves deeper review.
Data freshness: Financial data last refreshed 2026-09-19.
Research-input completeness: 100% of the scoring inputs required for this public page are currently available.
How to research HAO
Start by understanding how the company makes money. Then compare revenue and earnings trends, cash generation, debt, liquidity and valuation. Review the company's latest filings and earnings reports before acting on any score or model estimate.
Learn how to analyze a stock · Read the Wall Street Score methodology · Browse other stocks
Data may change as company filings and market prices update. Educational research only; not a buy or sell recommendation.